文章摘要
许丽华,张 允,仇俊兰,张 怀,潘承祺.LncRNA SOCS2-AS1、miR-454-3p在人胃癌组织中的表达及临床意义[J].,2024,(22):4327-4329
LncRNA SOCS2-AS1、miR-454-3p在人胃癌组织中的表达及临床意义
Expression and Clinical Significance of LncRNA SOCS2-AS1 and miR-454-3p in Human Gastric Cancer Tissues
投稿时间:2024-07-02  修订日期:2024-07-30
DOI:10.13241/j.cnki.pmb.2024.22.037
中文关键词: 胃癌  LncRNA SOCS2-AS1  miR-454-3p  病理特征  预后
英文关键词: Gastric cancer  LncRNA SOCS2-AS1  miR-454-3p  Pathological features  Prognosis
基金项目:江苏省科技厅社会发展-临床前沿技术项目(BE2018669)
作者单位E-mail
许丽华 南京大学医学院附属苏州医院肿瘤内科 江苏 苏州 215000 xulihua202406@163.com 
张 允 南京大学医学院附属苏州医院肿瘤内科 江苏 苏州 215000  
仇俊兰 南京大学医学院附属苏州医院肿瘤内科 江苏 苏州 215000  
张 怀 南京大学医学院附属苏州医院肿瘤内科 江苏 苏州 215000  
潘承祺 南京大学医学院附属苏州医院肿瘤内科 江苏 苏州 215000  
摘要点击次数: 51
全文下载次数: 40
中文摘要:
      摘要 目的:探讨长链非编码核糖核酸(LncRNA)细胞因子信号转导抑制因子2-反义转录本1(SOCS2-AS1)、微小核糖核酸(miRNA)-454-3p在人胃癌组织中的表达及临床意义。方法:选取120例行胃癌根治术患者的胃癌组织和癌旁组织。检测上述组织中LncRNA SOCS2-AS1、miR-454-3p表达。分析LncRNA SOCS2-AS1、miR-454-3p表达与胃癌患者临床病理特征和预后的关系,多因素COX回归分析胃癌患者预后不良的影响因素。结果:胃癌组织中LncRNA SOCS2-AS1、miR-454-3p表达均低于癌旁组织(P<0.05)。LncRNA SOCS2-AS1、miR-454-3p表达与分化程度、浸润深度、淋巴结转移、TNM分期有关(P<0.05)。LncRNA SOCS2-AS1低表达组3年总生存率(OS)低于LncRNA SOCS2-AS1高表达组,miR-454-3p低表达组3年OS低于miR-454-3p高表达组(P<0.05)。发生淋巴结转移、TNM分期Ⅲ期是胃癌患者预后不良的危险因素(P<0.05),miR-454-3p、LncRNA SOCS2-AS1高表达是胃癌患者预后不良的保护因素(P<0.05)。结论:胃癌组织中LncRNA SOCS2-AS1、miR-454-3p呈低表达,二者与胃癌患者病理特征及预后不良密切相关。
英文摘要:
      ABSTRACT Objective: To investigate the expression and clinical significance of long non-coding ribonucleic acids (LncRNA) cytokine signal transduction inhibitor 2-antisense transcript 1 (SOCS2-AS1) and micribonucleic acid (miRNA)-454-3p in human gastric cancer tissues. Methods: The gastric cancer tissues and adjacent tissues of 120 patients undergoing radical gastrectomy were selected. The expression of LncRNA SOCS2-AS1 and miR-454-3p in above-mentioned tissues were detected. After 3 years of follow-up, the relationship between the expression of LncRNA SOCS2-AS1, miR-454-3p and the clinical pathological characteristics and prognosis of gastric cancer patients by analysis, and the influencing factors of poor prognosis in gastric cancer patients were analyzed by multivariate COX regression. Results: The expression of LncRNA SOCS2-AS1 and miR-454-3p in gastric cancer tissues was lower than that in adjacent tissues (P<0.05). The expression of LncRNA SOCS2-AS1 and miR-454-3p was related to the degree of differentiation, depth of invasion, lymph node metastasis and TNM stage (P<0.05). The 3-year overall survival (OS) in LncRNA SOCS2-AS1 low expression group was lower than that in LncRNA SOCS2-AS1 high expression group, and the 3-year OS in miR-454-3p low expression group was lower than that in miR-454-3p high expression group (P<0.05). Lymph node metastasis and TNM stage III were risk factors for poor prognosis in gastric cancer patients (P<0.05). High expression of miR-454-3p and LncRNA SOCS2-AS1 was a protective factor for poor prognosis in gastric cancer patients (P<0.05). Conclusion: The low expression of LncRNA SOCS2-AS1 and miR-454-3p in gastric cancer tissues is closely related to the pathological characteristics and poor prognosis of gastric cancer patients.
查看全文   查看/发表评论  下载PDF阅读器
关闭